CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 41 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $20,000 | -91.3% | 11,800 | -78.1% | 0.00% | – |
| Q2 2018 | $230,000 | +618.8% | 53,874 | +888.0% | 0.00% | – |
| Q1 2018 | $32,000 | +68.4% | 5,453 | +30.8% | 0.00% | – |
| Q4 2017 | $19,000 | -80.4% | 4,170 | -76.4% | 0.00% | – |
| Q3 2017 | $97,000 | – | 17,661 | +88205.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 20 | -99.5% | 0.00% | – |
| Q4 2016 | $23,000 | – | 4,428 | +31528.6% | 0.00% | – |
| Q3 2016 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 14 | -99.6% | 0.00% | – |
| Q1 2015 | $22,000 | +100.0% | 3,122 | +161.7% | 0.00% | – |
| Q2 2014 | $11,000 | +450.0% | 1,193 | +403.4% | 0.00% | – |
| Q1 2014 | $2,000 | +100.0% | 237 | +79.5% | 0.00% | – |
| Q4 2013 | $1,000 | -66.7% | 132 | -61.1% | 0.00% | – |
| Q3 2013 | $3,000 | – | 339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
| COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
| Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
| Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
| ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |